MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Cantor Fitzgerald Maintains Neutral on Merck & Co, Raises Price Target to $145
Analyst Ratings
MRK
Oct 8
AI-curated analysis for informational purposes only — not investment advice.
Cantor Fitzgerald Maintains Neutral on Merck & Co, Raises Price Target to $145
Read the full story at benzinga.com →